NCT04206007View on ClinicalTrials.gov

Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease

PHASE1UnknownINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 11, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions
Chronic Obstructive Pulmonary Disease Moderate
Interventions
BIOLOGICAL

UMC119-06

Cohort 1: Low does of UMC119-06 Cohort 2: Medium does of UMC119- 06 Cohort 3: High does of UMC119-06

Trial Locations (1)

23561

Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City

Sponsors
All Listed Sponsors
lead

Meridigen Biotech Co., Ltd.

INDUSTRY

NCT04206007 - Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter